Combinations of pyrazole kinase inhibitors
US8404718B2 · kind B2 · utility
5Cited by
24References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 1, 2010 |
| Grant date | Mar 26, 2013 |
| Priority date | — |
| Expiry date | Dec 20, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a combination comprising a cytotoxic compound, a signalling inhibitor, an ancillary agent, or two or more further anti-cancer agents, and a compound having the formula (Ib):or salts or tautomers or N-oxides or solvates thereof;wherein
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.